These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8932067)

  • 21. Recombinant human GM-CSF in the treatment of poorly healing wounds.
    Groves RW; Schmidt-Lucke JA
    Adv Skin Wound Care; 2000; 13(3 Pt 1):107-12. PubMed ID: 11075003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of neonatal anemia with recombinant human erythropoietin: a cost-benefit analysis].
    Schefels J; Merz U; Hörnchen H
    Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():1-5. PubMed ID: 10612190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Homing efficiency and hematopoietic reconstitution of bone marrow-derived stroma cells expanded by recombinant human macrophage-colony stimulating factor in vitro.
    Jin-Xiang F; Xiaofeng S; Jun-Chuan Q; Yan G; Xue-Guang Z
    Exp Hematol; 2004 Dec; 32(12):1204-11. PubMed ID: 15588945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
    Cardier JE; Erickson-Miller CL; Murphy MJ
    Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [High-dose chemotherapy supported by peripheral blood stem cells to treat intermediate--and high-grade non-Hodgkin's lymphomas].
    Ji Y; Ji S; Ju X
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):471-5. PubMed ID: 9387307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human erythropoietin in combined treatment with granulocyte- or granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes.
    Kasper C; Zahner J; Sayer HG
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):497-502. PubMed ID: 12242514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The administration of growth factors post-PBPC transplantation abrogates the dose-effect of CFU-GM on the rate of PMN recovery.
    Pierelli L; Menichella G; Foddai ML; Scambia G; Salerno G; Benedetti Panici P
    Bone Marrow Transplant; 1996 Jun; 17(6):1189-90. PubMed ID: 8807136
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant erythropoietin in anemia of prematurity: five years later.
    Shannon K
    Pediatrics; 1993 Oct; 92(4):614-7. PubMed ID: 8414840
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of epoetin (erythropoietin) in the anemia of prematurity.
    Novick D; Moore TB; Feig SA
    West J Med; 1995 Apr; 162(4):355-6. PubMed ID: 7747503
    [No Abstract]   [Full Text] [Related]  

  • 31. Erythropoietin therapy for anemia of prematurity.
    Merchant RH; Sonigara S; Sanghvi KP
    Indian Pediatr; 1996 Apr; 33(4):323-6. PubMed ID: 8772909
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of haemopoietic growth factors in the pathogenesis of the early anaemia of premature infants.
    Han P; Stacy D; Story C; Owens PC
    Br J Haematol; 1995 Oct; 91(2):327-9. PubMed ID: 8547069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of erythropoietin in premature neonates: controversies and the future.
    Wandstrat TL; Kaplan B
    Ann Pharmacother; 1995 Feb; 29(2):166-73. PubMed ID: 7756716
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of early anemia of the premature infant with vitamin E].
    Tancredi F; Sacco R; Martucci E; Tarallo S
    Pediatria (Napoli); 1968 Aug; 76(4):571-8. PubMed ID: 5754146
    [No Abstract]   [Full Text] [Related]  

  • 35. Recombinant haemopoietic growth factors in the newborn--will they be useful?
    Wardrop CA; Holland BM
    Eur J Pediatr; 1995; 154(8 Suppl 3):S13-4. PubMed ID: 7588982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic growth factors: Part I.
    Wolfe M; Wandstrat TL
    Neonatal Netw; 1996 Sep; 15(6):7-11. PubMed ID: 8932067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietic growth factors: Part II.
    Wandstrat TL; Wolfe M
    Neonatal Netw; 1996 Oct; 15(7):25-8. PubMed ID: 9035641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V; Ongun H; Yeşilipek MA; Yeğin O
    Turk J Pediatr; 1999; 41(1):117-20. PubMed ID: 10770686
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease.
    Kovacic JC; Muller DW; Graham RM
    J Mol Cell Cardiol; 2007 Jan; 42(1):19-33. PubMed ID: 17109881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF).
    Akasheh M; Eastwood D; Vesole DH
    Bone Marrow Transplant; 2003 Jan; 31(2):113-6. PubMed ID: 12621492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.